← Back
Data updated: Mar 10, 2026
LUOXIN AUROVITAS
Respiratory
LUOXIN AUROVITAS is a generic drug manufacturer focused on Respiratory.
2016
Since
5
Drugs
-
Trials
14
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
IPRATROPIUM BROMIDE 2026-02-23
ALBUTEROL SULFATE 2025-12-01
ALBUTEROL SULFATE 2025-11-21
Labeling
ALBUTEROL SULFATE 2025-03-12
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE 2025-02-24
Labeling
IPRATROPIUM BROMIDE 2025-02-07
IPRATROPIUM BROMIDE 2025-01-27
IPRATROPIUM BROMIDE 2025-01-14
IPRATROPIUM BROMIDE 2024-11-19
Labeling
IPRATROPIUM BROMIDE 2024-11-15
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Respiratory 100%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (2)
Company Info
- First Approval
- 2016-10-27
- Latest
- 2023-07-21
- Applications
- 7